Cushing MLP Total Return Fund (SRV) Plans $0.09 Monthly Dividend
Cushing MLP Total Return Fund (NYSE:SRV) declared a monthly dividend on Thursday, February 1st, Zacks reports. Shareholders of record on Friday, February 16th will be paid a dividend of 0.09 per share by the investment management company on Wednesday, February 28th. This represents a $1.08 dividend on an annualized basis and a yield of 9.02%. The ex-dividend date is Thursday, February 15th.
Cushing MLP Total Return Fund has decreased its dividend payment by an average of 37.8% annually over the last three years.
Cushing MLP Total Return Fund (NYSE SRV) opened at $11.98 on Wednesday. The company has a market cap of $80.00, a PE ratio of -6.89 and a beta of 1.41. Cushing MLP Total Return Fund has a one year low of $10.00 and a one year high of $15.00.
ILLEGAL ACTIVITY NOTICE: “Cushing MLP Total Return Fund (SRV) Plans $0.09 Monthly Dividend” was published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark law. The correct version of this news story can be viewed at https://theolympiareport.com/2018/02/14/cushing-mlp-total-return-fund-srv-plans-0-09-monthly-dividend.html.
The Cushing MLP Total Return Fund (the Fund) is a non-diversified, closed-end management investment company. The Fund’s investment objective is to obtain a high after-tax total return from a combination of capital appreciation and current income. The Fund, under normal market conditions, invests at least 80% of its assets (net assets plus any borrowings for investment purposes) in a portfolio of master limited partnerships (MLPs) and MLP-related investments.
Receive News & Ratings for Cushing MLP Total Return Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cushing MLP Total Return Fund and related companies with MarketBeat.com's FREE daily email newsletter.